Correlation Between HealthStream and Neuropace
Can any of the company-specific risk be diversified away by investing in both HealthStream and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HealthStream and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HealthStream and Neuropace, you can compare the effects of market volatilities on HealthStream and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HealthStream with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of HealthStream and Neuropace.
Diversification Opportunities for HealthStream and Neuropace
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between HealthStream and Neuropace is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding HealthStream and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and HealthStream is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HealthStream are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of HealthStream i.e., HealthStream and Neuropace go up and down completely randomly.
Pair Corralation between HealthStream and Neuropace
Given the investment horizon of 90 days HealthStream is expected to generate 0.25 times more return on investment than Neuropace. However, HealthStream is 3.94 times less risky than Neuropace. It trades about -0.06 of its potential returns per unit of risk. Neuropace is currently generating about -0.09 per unit of risk. If you would invest 2,742 in HealthStream on May 12, 2025 and sell it today you would lose (144.00) from holding HealthStream or give up 5.25% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
HealthStream vs. Neuropace
Performance |
Timeline |
HealthStream |
Neuropace |
HealthStream and Neuropace Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HealthStream and Neuropace
The main advantage of trading using opposite HealthStream and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HealthStream position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.HealthStream vs. TruBridge | HealthStream vs. National Research Corp | HealthStream vs. Forian Inc | HealthStream vs. HealthEquity |
Neuropace vs. LivaNova PLC | Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |